221 related articles for article (PubMed ID: 11896119)
21. Low dose continuous infusion doxorubicin in children and young adults.
Kynaston JA; Pearson AD; Kernahan J; Lucraft H; Barstow D; Thompson A; Craft AW
Med Pediatr Oncol; 1993; 21(7):494-8. PubMed ID: 8341217
[TBL] [Abstract][Full Text] [Related]
22. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
Lipshultz SE; Rifai N; Dalton VM; Levy DE; Silverman LB; Lipsitz SR; Colan SD; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE
N Engl J Med; 2004 Jul; 351(2):145-53. PubMed ID: 15247354
[TBL] [Abstract][Full Text] [Related]
23. Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
Barry EV; Vrooman LM; Dahlberg SE; Neuberg DS; Asselin BL; Athale UH; Clavell LA; Larsen EC; Moghrabi A; Samson Y; Schorin MA; Cohen HJ; Lipshultz SE; Sallan SE; Silverman LB
J Clin Oncol; 2008 Mar; 26(7):1106-11. PubMed ID: 18309945
[TBL] [Abstract][Full Text] [Related]
24. Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer.
Chow EJ; Aggarwal S; Doody DR; Aplenc R; Armenian SH; Baker KS; Bhatia S; Blythe N; Colan SD; Constine LS; Freyer DR; Kopp LM; Laverdière C; Leisenring WM; Sasaki N; Vrooman LM; Asselin BL; Schwartz CL; Lipshultz SE
J Clin Oncol; 2023 Apr; 41(12):2248-2257. PubMed ID: 36669148
[TBL] [Abstract][Full Text] [Related]
25. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
[TBL] [Abstract][Full Text] [Related]
26. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
27. High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia.
Lockhart S; Plunkett W; Jeha S; Ramirez I; Zipf T; Cork A; Pinkel D
J Clin Oncol; 1994 Mar; 12(3):587-95. PubMed ID: 8120558
[TBL] [Abstract][Full Text] [Related]
28. Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemia.
Goldberg JM; Scully RE; Sallan SE; Lipshultz SE
J Pediatr Hematol Oncol; 2012 Jul; 34(5):395-7. PubMed ID: 22584777
[TBL] [Abstract][Full Text] [Related]
29. Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Jarfelt M; Andersen NH; Glosli H; Jahnukainen K; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
Eur J Haematol; 2016 Jul; 97(1):55-62. PubMed ID: 26383901
[TBL] [Abstract][Full Text] [Related]
30. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
Lipshultz SE; Lipsitz SR; Sallan SE; Simbre VC; Shaikh SL; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2002 Dec; 20(23):4517-22. PubMed ID: 12454107
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin cardiotoxicity in children: comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration.
Ewer MS; Jaffe N; Ried H; Zietz HA; Benjamin RS
Med Pediatr Oncol; 1998 Dec; 31(6):512-5. PubMed ID: 9835904
[TBL] [Abstract][Full Text] [Related]
32. [Adriamycin (doxorubicin)].
Ogura M
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1331-8. PubMed ID: 11681238
[TBL] [Abstract][Full Text] [Related]
33. [Dilated cardiomyopathy post-chemotherapy].
Sbrana F; Greco P; Rovai D
Recenti Prog Med; 2009 Mar; 100(3):132-6. PubMed ID: 19475840
[TBL] [Abstract][Full Text] [Related]
34. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.
Legha SS; Benjamin RS; Mackay B; Ewer M; Wallace S; Valdivieso M; Rasmussen SL; Blumenschein GR; Freireich EJ
Ann Intern Med; 1982 Feb; 96(2):133-9. PubMed ID: 7059060
[TBL] [Abstract][Full Text] [Related]
35. [The effect of the anthracycline derivative doxorubicin on myocardial function in children].
Sobotka-Plojhar MA; Daniëls O; Rohmer J; Veerman AJ; Lippens R; van Lier H
Ned Tijdschr Geneeskd; 1989 Jul; 133(27):1367-70. PubMed ID: 2797225
[TBL] [Abstract][Full Text] [Related]
36. Assessment of late cardiotoxicity of pirarubicin (THP) in children with acute lymphoblastic leukemia.
Shimomura Y; Baba R; Watanabe A; Horikoshi Y; Asami K; Hyakuna N; Iwai A; Matsushita T; Yamaji K; Hori T; Tsurusawa M;
Pediatr Blood Cancer; 2011 Sep; 57(3):461-6. PubMed ID: 21298773
[TBL] [Abstract][Full Text] [Related]
37. Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.
Lipshultz SE; Anderson LM; Miller TL; Gerschenson M; Stevenson KE; Neuberg DS; Franco VI; LiButti DE; Silverman LB; Vrooman LM; Sallan SE;
Cancer; 2016 Mar; 122(6):946-53. PubMed ID: 26762648
[TBL] [Abstract][Full Text] [Related]
38. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
Sivaprakasam P; Gupta AA; Greenberg ML; Capra M; Nathan PC
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e226-30. PubMed ID: 21792028
[TBL] [Abstract][Full Text] [Related]
39. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration.
Toyoda Y; Okada M; Kashem MA
J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1367-73. PubMed ID: 9628680
[TBL] [Abstract][Full Text] [Related]
40. [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
Rubio JA; Pulpón LA; Cavero MA; Oteo JF; Maicas C; Silva L; Serrano-Fiz S; Burgos R; Artaza M; Téllez G
Rev Esp Cardiol; 1994 Nov; 47(11):777-9. PubMed ID: 7800910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
